FR2299034B1 - - Google Patents

Info

Publication number
FR2299034B1
FR2299034B1 FR7601975A FR7601975A FR2299034B1 FR 2299034 B1 FR2299034 B1 FR 2299034B1 FR 7601975 A FR7601975 A FR 7601975A FR 7601975 A FR7601975 A FR 7601975A FR 2299034 B1 FR2299034 B1 FR 2299034B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7601975A
Other versions
FR2299034A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of FR2299034A1 publication Critical patent/FR2299034A1/fr
Application granted granted Critical
Publication of FR2299034B1 publication Critical patent/FR2299034B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/008—Ketals at position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/004—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0048—Alkynyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096—Alkynyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Fodder In General (AREA)
FR7601975A 1975-01-30 1976-01-26 Nouveaux 13-ethinyl-steroides et procede pour leur preparation Granted FR2299034A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH112375A CH606101A5 (fr) 1975-01-30 1975-01-30

Publications (2)

Publication Number Publication Date
FR2299034A1 FR2299034A1 (fr) 1976-08-27
FR2299034B1 true FR2299034B1 (fr) 1979-09-21

Family

ID=4203021

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7601975A Granted FR2299034A1 (fr) 1975-01-30 1976-01-26 Nouveaux 13-ethinyl-steroides et procede pour leur preparation

Country Status (15)

Country Link
US (1) US4052421A (fr)
JP (1) JPS51100068A (fr)
AU (1) AU503505B2 (fr)
BE (1) BE838019A (fr)
CA (1) CA1065302A (fr)
CH (1) CH606101A5 (fr)
DE (1) DE2602891A1 (fr)
DK (1) DK138698B (fr)
ES (1) ES444689A1 (fr)
FR (1) FR2299034A1 (fr)
GB (1) GB1514621A (fr)
IE (1) IE42468B1 (fr)
IL (1) IL48937A (fr)
SE (1) SE7514455L (fr)
ZA (1) ZA76506B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4297350A (en) * 1978-10-10 1981-10-27 The Upjohn Company Male contraceptive steroids and methods of use
US4289762A (en) * 1980-06-27 1981-09-15 Merrell Dow Pharmaceuticals Inc. 10-(1,2-Propadienyl) steroids as irreversible aromatase inhibitors
US4293548A (en) * 1980-09-02 1981-10-06 Merrell Dow Pharmaceuticals Inc. 18-Substituted pregn-4-ene-3,20-diones
ATE527192T1 (de) 2009-03-02 2011-10-15 Sala Jaime Marti Rotationsförderer für leichte gegenstände

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3959322A (en) * 1960-09-22 1976-05-25 Herchel Smith Synthesis of 13-alkyl-gon-4-ones
US3267005A (en) * 1963-10-23 1966-08-16 American Home Prod Resolution of racemic delta4-3-ketosteroids
US3798215A (en) * 1968-11-25 1974-03-19 Sandoz Ag Propadienyl-substituted carbinols

Also Published As

Publication number Publication date
GB1514621A (en) 1978-06-14
IE42468L (en) 1976-07-30
CH606101A5 (fr) 1978-10-13
FR2299034A1 (fr) 1976-08-27
IE42468B1 (en) 1980-08-13
CA1065302A (fr) 1979-10-30
US4052421A (en) 1977-10-04
DE2602891A1 (de) 1976-08-05
SE7514455L (sv) 1976-08-02
ES444689A1 (es) 1977-05-16
IL48937A (en) 1979-07-25
AU503505B2 (en) 1979-09-06
BE838019A (fr) 1976-07-29
JPS51100068A (fr) 1976-09-03
DK138698C (fr) 1979-03-19
AU1064476A (en) 1977-08-04
IL48937A0 (en) 1976-03-31
DK563775A (fr) 1976-07-31
DK138698B (da) 1978-10-16
ZA76506B (en) 1977-01-26

Similar Documents

Publication Publication Date Title
FR2304487B1 (fr)
FR2305660B1 (fr)
JPS5413261B2 (fr)
FR2296380B1 (fr)
JPS531598B2 (fr)
JPS523417U (fr)
JPS51104652A (fr)
JPS5616912B2 (fr)
JPS51153712U (fr)
JPS5188194A (fr)
AU489798B2 (fr)
JPS5319940B1 (fr)
JPS5182407U (fr)
JPS5215402U (fr)
JPS5252857U (fr)
JPS5244570U (fr)
JPS51139483U (fr)
JPS51113134U (fr)
IN144701B (fr)
JPS5291481U (fr)
JPS5280900U (fr)
CH579134A5 (fr)
CH605184A5 (fr)
CH583552A5 (fr)
CH581939A5 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse